GlassScriptPhysician profile
Debra Larkins
NPI 1912900051
$1,284.68
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $71.18 · 2022: $424 · 2023: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $337.18 | 2019-2023 | Acessa Provu System, Coolseal Generator |
| Minerva Surgical, INC | $306.32 | 2019-2023 | |
| Abbvie INC. | $268.17 | 2019-2023 | |
| Exeltis, USA INC. | $91.14 | 2022-2023 | Slynd |
| Coopersurgical, INC. | $60.15 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $50.89 | 2019-2023 | Vaxelis, Rotateq, Vaxneuvance |
| Amgen INC. | $40.07 | 2019 | |
| Therapeuticsmd, INC. | $38.55 | 2019-2022 | |
| Duchesnay USA Incorporated | $32.55 | 2019 | |
| Mayne Pharma Commercial LLC | $17.07 | 2022 | |
| Pfizer INC. | $16.27 | 2023 | |
| Baxter Healthcare | $16.15 | 2019 | |
| Meditrina | $10.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Larkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.